Ranbaxy Laboratories, India's largest pharmaceutical company, has notified that Ranbaxy Malaysia Sdn Bhd, a subsidiary of the company has started the marketing of anti-hypertensive tablet - Covance - in the Malaysian market.

Ranbaxy is the first company to launch a generic version of Losartan K in Malaysia, in the strengths of 50 and 100 mg.

Covance Tablets are indicated and employed as an antihypertensive, and the market size of Losartan K tablets in Malaysia is $6.29 million.

The scrip of the company today closed at Rs 280 on BSE. The counter has made 52-week-high and low of Rs 542 and Rs 133 respectively.